SEC Form 4 · accession 0001171843-16-012533
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul J Hastings
Director
Period of report
Oct 18, 2016
Accepted (ET)
Oct 20, 2016 · 7:56 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.00 | Oct 18, 2016 | A | 13,333 | A | — | Oct 17, 2026 | Common Stock, $0.001 par value | 13,333 | 13,333 | D |
Explanation of responses
- F1The options were granted on October 18, 2016 and will vest annually over a three-year period measured from the date of grant.